Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,969 | Dovepress* | 4,531+ | 883 | 5,414 | |
| PubMed Central* | 438 | 128 | 566 | ||
| Totals | 4,969 | 1,011 | 5,980 | ||
| *Since 20 March 2019 | |||||
View citations on PubMed Central and Google Scholar